Nature Communications (Feb 2022)
AusTrakka: Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic
Abstract
The COVID-19 pandemic has accelerated the demand for near real-time analysis and dissemination of pathogen genomic data. In this comment, the authors describe how Australia has developed and rolled out its SARS-CoV-2 genomics platform, AusTrakka, and used it to support public health action.